Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $25.7800 (2.38%) ($24.9000 - $26.0000) on Thu. Dec. 7, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.41% (three month average) | RSI | 56 | Latest Price | $25.7800(2.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.2% a day on average for past five trading days. | Weekly Trend | EDIT advances 2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(63%) XBI(62%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.205% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-5%) UUP(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.205% (StdDev 4.41%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
Resistance Level | $26.18 | 5 Day Moving Average | $27.18(-5.15%) | 10 Day Moving Average | $27.26(-5.43%) | 20 Day Moving Average | $26.18(-1.53%) | To recent high | -13.7% | To recent low | 29.4% | Market Cap | $1.601b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |